These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 9054839)

  • 1. Vasopressin deficiency contributes to the vasodilation of septic shock.
    Landry DW; Levin HR; Gallant EM; Ashton RC; Seo S; D'Alessandro D; Oz MC; Oliver JA
    Circulation; 1997 Mar; 95(5):1122-5. PubMed ID: 9054839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose vasopressin in the treatment of vasodilatory septic shock.
    Malay MB; Ashton RC; Landry DW; Townsend RN
    J Trauma; 1999 Oct; 47(4):699-703; discussion 703-5. PubMed ID: 10528604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of vasopressin deficiency in the vasodilation of septic shock.
    Reid IA
    Circulation; 1997 Mar; 95(5):1108-10. PubMed ID: 9054835
    [No Abstract]   [Full Text] [Related]  

  • 4. Physiology of vasopressin relevant to management of septic shock.
    Holmes CL; Patel BM; Russell JA; Walley KR
    Chest; 2001 Sep; 120(3):989-1002. PubMed ID: 11555538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin in vasodilatory and septic shock.
    Russell JA
    Curr Opin Crit Care; 2007 Aug; 13(4):383-91. PubMed ID: 17599007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating vasopressin levels in septic shock.
    Sharshar T; Blanchard A; Paillard M; Raphael JC; Gajdos P; Annane D
    Crit Care Med; 2003 Jun; 31(6):1752-8. PubMed ID: 12794416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement.
    Argenziano M; Choudhri AF; Oz MC; Rose EA; Smith CR; Landry DW
    Circulation; 1997 Nov; 96(9 Suppl):II-286-90. PubMed ID: 9386112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased vasopressin responsiveness in vasodilatory septic shock-like conditions.
    Leone M; Boyle WA
    Crit Care Med; 2006 Apr; 34(4):1126-30. PubMed ID: 16484914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin deficiency and vasodilatory state in end-stage liver disease.
    Wagener G; Kovalevskaya G; Minhaz M; Mattis F; Emond JC; Landry DW
    J Cardiothorac Vasc Anesth; 2011 Aug; 25(4):665-70. PubMed ID: 21126886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine vasopressin in the treatment of vasodilatory septic shock.
    Holmes CL; Walley KR
    Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):275-86. PubMed ID: 18683474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of short-term vasopressin infusion during severe septic shock.
    Patel BM; Chittock DR; Russell JA; Walley KR
    Anesthesiology; 2002 Mar; 96(3):576-82. PubMed ID: 11873030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent.
    Argenziano M; Chen JM; Choudhri AF; Cullinane S; Garfein E; Weinberg AD; Smith CR; Rose EA; Landry DW; Oz MC
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):973-80. PubMed ID: 9832689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors.
    Chen JM; Cullinane S; Spanier TB; Artrip JH; John R; Edwards NM; Oz MC; Landry DW
    Circulation; 1999 Nov; 100(19 Suppl):II244-6. PubMed ID: 10567311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock.
    Morales DL; Gregg D; Helman DN; Williams MR; Naka Y; Landry DW; Oz MC
    Ann Thorac Surg; 2000 Jan; 69(1):102-6. PubMed ID: 10654495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock.
    Tsuneyoshi I; Yamada H; Kakihana Y; Nakamura M; Nakano Y; Boyle WA
    Crit Care Med; 2001 Mar; 29(3):487-93. PubMed ID: 11373409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indications of vasopressin in the management of septic shock].
    Delmas A; Leone M; Rousseau S; Albanèse J; Martin C
    Ann Fr Anesth Reanim; 2003 Jul; 22(7):600-8. PubMed ID: 12946492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis.
    Dünser MW; Mayr AJ; Ulmer H; Ritsch N; Knotzer H; Pajk W; Luckner G; Mutz NJ; Hasibeder WR
    Anesth Analg; 2001 Jul; 93(1):7-13. PubMed ID: 11429329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of the vasoconstrictor effect of vasopressin in septic shock.
    Malay MB; Ashton JL; Dahl K; Savage EB; Burchell SA; Ashton RC; Sciacca RR; Oliver JA; Landry DW
    Crit Care Med; 2004 Jun; 32(6):1327-31. PubMed ID: 15187515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin deficiency and vasodilation of septic shock.
    Goldsmith SR
    Circulation; 1998 Jan; 97(3):292-3. PubMed ID: 9462535
    [No Abstract]   [Full Text] [Related]  

  • 20. Push-Dose Vasopressin for Hypotension in Septic Shock.
    Nowadly CD; Catlin JR; Fontenette RW
    J Emerg Med; 2020 Feb; 58(2):313-316. PubMed ID: 32173168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.